Stem Cells for Knees: Promising Treatment or Hoax?WebMDTreatments with stem cells — which can grow into different types of cells — are booming in the U.S., with an estimated 500 or more clinics in operation. Some clinics offer treatment for condition… Continue reading
Science Daily |
Immunotherapy for glioblastoma well tolerated; survival gains observed
Science Daily “This is a small study, but it’s one in a sequence of clinical trials we have conducted to explore the use of an immunotherapy that specifically targets a protein on glioblastoma tumors,” said Duke’s Kristen Batich, M.D., Ph.D., lead author of a study … News Brain Cancer Vaccine–Chemotherapy Combo …Genetic Engineering & Biotechnology News Vaccine Targeting Brain Tumors Seems Safe in StudyWebMD |
Science Daily |
Immunotherapy for glioblastoma well tolerated; survival gains observed
Science Daily “This is a small study, but it’s one in a sequence of clinical trials we have conducted to explore the use of an immunotherapy that specifically targets a protein on glioblastoma tumors,” said Duke’s Kristen Batich, M.D., Ph.D., lead author of a study … |
Seeking Alpha |
CAR–T Cell Therapy Means A Lot More Than One Or Two New Drug Approvals
Seeking Alpha The answer is that CAR–T cells present a few extra advantages to ramp up the immune response: the CAR itself – The name of the technique gives this away. “Chimeric” isn’t just a cool word (which it certainly is); it signifies that we’ve done something … |
Insider Financial |
Catching Up With US Stem Cell Inc (OTCMKTS:USRM) Ahead Of A Rebalance
Insider Financial When we first looked at US Stem Cell Inc (OTCMKTS:USRM), we urged our readers to look beyond the metrics, and to try and form a bias based on what the company was trying to achieve, and in what space. At the time (beginning of March this year), the … Theraputic Stem Cell-Sheet Transplantation May Improve Cardiomyopathy SymptomsThe Cardiology Advisor (registration) How Medical Research Is Boosting Connecticut’s EconomyYale News US Stem Cell Inc (OTCMKTS:USRM) Gets Investment Up To $5M from (GACP)The Oracle Dispatch Medgadget (blog) –Yahoo Finance –MilTech all 23 news articles » |
KQED |
Monsanto’s Driverless Car: Is CRISPR Gene Editing Driving Seed Consolidation?
KQED Over the past year, the company has announced several licensing agreements that will allow it to access gene-editing technologies, such as CRISPR/Cas9 and CRISPR–Cpf1 (which is said to be more precise), as well as a tool from Dow AgroScience called … Statement and background on CRISPR patent decision | Broad InstituteBroad Institute UC appeals US patent board decision on CRISPR-Cas9UC Berkeley |